ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
According to ASP Isotopes Inc. Common Stock's latest financial reports the company's current revenue (TTM) is $433.03 K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
---|---|---|---|---|---|
2023 | $433.03 K | $138.97 K | $-16,144,282 | $-16,300,259 | $-16,286,234 |
2022 | $ | $-72,570 | $-4,872,569 | $-4,945,139 | $-4,791,230 |
2021 | $ | $-19,376 | $-2,588,551 | $-2,607,927 | $-2,607,927 |
2019 | $22.63 M | $10.76 M | $3.84 M | $-10,360,000 | $-10,256,000 |